AB

Annovation Biopharma

Acquired

Next-generation anesthetic agents for safer surgical care

Cambridge, United States · Founded 2009 · $8.0M raised

Employees
1–10
Founded
2009
Business Model
B2B
Total Funding
$8.0M
Last Round
$8.0M Venture Round
Rounds
1

About

Annovation Biopharma, Inc. was a pharmaceutical company developing next-generation anesthetic agents in the fields of anesthesia, sedation, and sleep. Founded in 2009 and based in Cambridge, Massachusetts, the company advanced an MGH-derived lead compound, ABP-700, designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. Annovation raised an $8 million Series A in 2012 led by Atlas Venture, with participation from Partners Innovation Fund and The Medicines Company. The company was subsequently acquired by The Medicines Company in February 2015 for $61.6 million in cash and milestones.

Summary

Annovation Biopharma is a Biotech company based in Cambridge, United States, founded in 2009. It has raised $8.0M in total across 1 round. Investors include Atlas Venture and Partners Innovation Fund.

Funding History

Venture RoundVenture Round
$8.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Annovation Biopharma on Indexed.vc
<a href="https://indexed.vc/companies/annovation-biopharma"><img src="https://indexed.vc/api/badge/company/annovation-biopharma" alt="Annovation Biopharma on Indexed.vc" width="260" height="76" /></a>